Found 8 matching trials
PD1 Combined With Chemotherapy for Adjuvant Treatment of Gastric Cancer
PHASE3This multicenter, randomized, double-blind phase III study intends to recru...
Status
Active Not Recruiting
Location
The First Affiliated Hospital of Bengbu Medical College
Minimal Residual Disease Guiding Adjuvant Therapy in Stage I NSCLC
NAThis investigator-initiated study aims to evaluate the effectiveness of min...
Location
Dongguan People's Hospital
A Study of RC48-ADC Combination Therapies as First-line Treatment in Advanced Metastatic Gastric Cancer
PHASE2This is a Phase II/III, randomized, multicenter, open-label clinical trial ...
Status
Active Not Recruiting
Location
Beijing Cancer Hospital
Toripalimab or Placebo With Paclitaxel and Cisplatin in Esophageal Squamous Cell Carcinoma
PHASE3This is one randomized, double-blind, multi-center, placebo-controlled phas...
Location
Sun Yat-Sen University Cancer Center
JS001 Combination Therapy in NSCLC Negative Driving Gene After First-line Chemotherapy.
PHASE2This is a phase II, open, single-center clinical study to evaluate the effi...
Location
Sun Yat-Sen University Cancer Center
The Efficacy and Safety Study of TORIPALIMAB INJECTION Combined With Chemotherapy for Nasophapyngeal Cancer
PHASE3This is a randomized, placebo-controlled, multi-center, double blinded, Pha...
Location
Cancer Hospital, Chinese Academy of Medical Sciences
Toripalimab vs. Placebo Wtih GP Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
PHASE3The main questions it aims to answer are:
1. Does the combination of GP in...
Status
Active Not Recruiting
Location
Fujian Cancer Hospital
A Study to Evaluate the Efficacy and Safety of Toripalimab or Placebo Combined With Chemotherapy in Treatment-naive Advanced NSCLC
PHASE3This is one randomized, double-blind, placebo-controlled, multi-center, pha...
Location
Cancer Hospital Chinese Academy of Medical Sciences